E. Tanaka

Mechanism of acceleration of wound healing by basic fibroblast growth factor in genetically diabetic mice.

T. Okuda, E. Tanaka, K. Ase, 1996, Biological & pharmaceutical bulletin.

A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer

H. Scher, A. Dzik-Jurasz, D. Rathkopf, 2010, Cancer Chemotherapy and Pharmacology.

Inhibition of in vivo tumor growth by the beta chemokine, TCA3.

M. Dorf, Y. Luo, H. Kawasaki, 1994, Journal of immunology.

Expression of Fas in renal cell carcinoma.

A. Hirose, E. Higashihara, S. Horie, 1997, Japanese journal of clinical oncology.

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

Glenn Heller, Lawrence Schwartz, Steven Larson, 2007, Clinical Cancer Research.

A phase I study of oral panobinostat (LBH589) alone and in combination with docetaxel (Doc) and prednisone in castration-resistant prostate cancer (CRPC)

P. Atadja, H. Scher, D. Rathkopf, 2008 .